Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia. | Blood Adv | 2023 | 37327118 | PubTator, text mining | PubMed |
| FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma. | Int J Med Sci | 2023 | 37324186 | PubTator, text mining | PubMed |
| Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer. | J Ovarian Res | 2023 | 37322531 | PubTator, text mining | PubMed |
| SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses. | Front Cell Dev Biol | 2023 | 37313439 | PubTator, text mining | PubMed |
| Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development. | Acta Pharm | 2023 | 37307368 | PubTator, text mining | PubMed |
| HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma. | Front Immunol | 2023 | 37304265 | PubTator, text mining | PubMed |
| Dissecting shared genetic architecture between obesity and multiple sclerosis. | EBioMedicine | 2023 | 37300932 | PubTator, text mining | PubMed |
| NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential. | Int J Mol Sci | 2023 | 37298470 | PubTator, text mining | PubMed |
| Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing. | Int J Mol Sci | 2023 | 37298418 | PubTator, text mining | PubMed |
| A Panorama of Immune Fighters Armored with CARs in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37297016 | PubTator, text mining | PubMed |
| Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates. | Pharmgenomics Pers Med | 2023 | 37293607 | PubTator, text mining | PubMed |
| Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis. | Front Immunol | 2023 | 37292210 | PubTator, text mining | PubMed |
| Insights into anti-tumor immunity via the polyomavirus shared across human Merkel cell carcinomas. | Front Immunol | 2023 | 37287968 | PubTator, text mining | PubMed |
| Herpes Simplex Virus 1 MicroRNAs: An Update. | Intervirology | 2023 | 37285807 | PubTator, text mining | PubMed |
| Editorial: The role of epigenetic modification in radiotherapy and immuno-oncology in cancer: from bench to clinical application. | Front Oncol | 2023 | 37260973 | PubTator, text mining | PubMed |
| Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes. | Front Oncol | 2023 | 37256178 | PubTator, text mining | PubMed |
| Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression. | Front Immunol | 2023 | 37256148 | PubTator, text mining | PubMed |
| Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell. | Adv Sci (Weinh) | 2023 | 37254712 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| Biological Insight and Recent Advancement in the Treatment of Neuroblastoma. | Int J Mol Sci | 2023 | 37239815 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=19